,outcome,arm 1,arm 2,comparative statistic,95% CI,p-value,note
0,intervention,PLD,doxorubicin,,,,
0,PFS,6.9,7.8 months,hazard ratio ( HR ) =1.00,0.82-1.22,NR,NR
0,Overall risk of cardiotoxicity,NR,significantly higher,HR=3.16,1.58-6.31,P<0.001,NR
